Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1412-1415
Published online before print June 5, 2003, doi: 10.1161/01.ATV.0000080687.94313.67
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
23/8/1412    most recent
01.ATV.0000080687.94313.67v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by MacLean, P. S.
Right arrow Articles by Barakat, H. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacLean, P. S.
Right arrow Articles by Barakat, H. A.
Related Collections
Right arrow Pericardial disease
Right arrow Cardiovascular imaging agents/Techniques
Right arrow Secretion
Right arrow CV surgery: aortic and vascular disease
Right arrow Endothelium/vascular type/nitric oxide
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2003;23:1412.)
© 2003 American Heart Association, Inc.


Atherosclerosis and Lipoproteins

Cholesteryl Ester Transfer Protein Expression Prevents Diet-Induced Atherosclerotic Lesions in Male db/db Mice

Paul S. MacLean; Joseph F. Bower; Satyaprasad Vadlamudi; Jody N. Osborne; John F. Bradfield; Hubert W. Burden; William H. Bensch; Raymond F. Kauffman; Hisham A. Barakat

From the Departments of Biochemistry (P.S.M., J.F.B., S.V., H.A.B.), Comparative Medicine (J.N.O., J.F.B.), and Anatomy and Cell Biology (H.W.B.), Brody School of Medicine, East Carolina University, Greenville, NC, and Lilly Research Laboratories (W.H.B., R.F.K.), a Division of Eli Lilly and Company, Indianapolis, Ind.

Correspondence to Paul S. MacLean, PhD, University of Colorado Health Sciences Center, Center for Human Nutrition, 4200 E 9th Ave, C225, Denver, CO 80262. E-mail Paul.MacLean{at}UCHSC.edu

Objective— Accompanying more atherogenic lipoprotein profiles and an increased incidence of atherosclerosis, plasma cholesteryl ester transfer protein (CETP) is depressed in diabetic obese patients compared with nondiabetic obese counterparts. The depressed levels of CETP in the plasma of diabetic obese individuals may contribute to the development of an atherogenic lipoprotein profile and atherogenesis. We have examined the effect of CETP expression on vascular health in the db/db model of diabetic obesity.

Methods and Results— Transgenic mice expressing the human CETP minigene were crossed with db/db strain, and 3 groups of offspring (CETP, db, and db/CETP) were placed on an atherogenic diet for 16 weeks. The proximal aorta was then excised and examined for the presence of atherosclerotic plaques. In db mice, 9 of 11 had intimal lesions with a mean area of 26 098±7486 µm2. No lesions greater than 1000 µm2 were observed in db/CETP or CETP mice. CETP-expressing mice had lower circulating cholesterol concentrations than db mice. Fractionating plasma lipids by FPLC indicated that the difference in total cholesterol was primarily attributable to differences in VLDL and LDL.

Conclusions— The expression of human CETP in db/db mice prevented the formation of diet-induced lesions, suggesting an antiatherogenic effect of CETP in the context of diabetic obesity.


Key Words: cholesterol • FPLC • VLDL • LDL • HDL obesity




This article has been cited by other articles:


Home page
CirculationHome page
H. Tanigawa, J. T. Billheimer, J.-i. Tohyama, Y. Zhang, G. Rothblat, and D. J. Rader
Expression of Cholesteryl Ester Transfer Protein in Mice Promotes Macrophage Reverse Cholesterol Transport
Circulation, September 11, 2007; 116(11): 1267 - 1273.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. Fazio and M. F. Linton
Sorting Out The Complexities of Reverse Cholesterol Transport: CETP Polymorphisms, HDL, and Coronary Disease.
J. Clin. Endocrinol. Metab., September 1, 2006; 91(9): 3273 - 3275.
[Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
S. Shetty, E. R.M. Eckhardt, S. R. Post, and D. R. van der Westhuyzen
Phosphatidylinositol-3-Kinase Regulates Scavenger Receptor Class B Type I Subcellular Localization and Selective Lipid Uptake in Hepatocytes
Arterioscler. Thromb. Vasc. Biol., September 1, 2006; 26(9): 2125 - 2131.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
P. S. MacLean, S. Vadlamudi, K. G. MacDonald, W. J. Pories, and H. A. Barakat
Suppression of Hepatic Cholesteryl Ester Transfer Protein Expression in Obese Humans with the Development of Type 2 Diabetes Mellitus
J. Clin. Endocrinol. Metab., April 1, 2005; 90(4): 2250 - 2258.
[Abstract] [Full Text] [PDF]